Diagnosis of Tardive Dyskinesia

  • Christopher G. Goetz


The syndrome of tardive dyskinesia (TD) encompasses a series of abnormal involuntary movements associated with chronic exposure to neuroleptic agents. To establish the diagnosis with confidence, the history of prolonged medication must accompany the movements that characterize TD. One feature without the other necessarily casts doubt on the diagnosis. Each diagnostic feature will be discussed briefly followed by a section on differential diagnosis.


Tardive Dyskinesia Cervical Dystonia Extrapyramidal Disorder Neuroleptic Agent Choreiform Movement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L. Uhrbrand and A. Faurbye, Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine, E.C.T. therapy. Psychopharmacologia 1: 408–418 (1960).CrossRefGoogle Scholar
  2. 2.
    M. Bourgeois and J. Tignol, Les dyskin£sies tardives des neuroleptiques. La Nov. Pres. Med. 6: 3649–3650 (1977).Google Scholar
  3. 3.
    C.G. Goetz and H.L. Klawans, Tardive Dyskinesia, in: “Psychiatric Aspects of Neurologic Disease II:” D.F. Benson, D. Blumer eds., Grunne and Stratton, NY (1982).Google Scholar
  4. 4.
    W.J. Weiner, C.G. Goetz, P.A. Nausieda and H.L. Klawans, Respiratory dyskinesias: extrapyramidal dysfunction presenting as shortness of breath. Ann. Int. Med. 88: 327–331 (1978).PubMedCrossRefGoogle Scholar
  5. 5.
    R.E. Burke, S. Fahn and J. Jankovic, Tardive dystonia. Neurology 31: 79 (1981).CrossRefGoogle Scholar
  6. 6.
    K. Jus, A. Jus and J. Gautier, Studies on the action of certain pharmacological agents on tardive and on the rabbit syndrome. Int. J. Clin. Pharmacol. 9: 138–145 (1974).PubMedGoogle Scholar
  7. 7.
    R. Sovner and A. Diamascio, Effect of benztrophine in the rabbit syndrome and tardive dyskinesia. Am. J. Psych. 134: 1301–1302 (1977).Google Scholar
  8. 8.
    A. Villeneuve, Rabbit syndrome-A peculiar extrapyramidal reaction. Can. Psychiatr. Assoc. J. 17: 69–72 (1972).Google Scholar
  9. 9.
    C.D. Marsden, D. Tarsy, R.J. Baldessarini, Spontaneous and drug- induced movement disorders in psychiatric patients, in: “Psychiatric Aspects of Neurologic Disease,” D.F. Benson, D. Blumer eds., New York, Grune & Stratton (1975).Google Scholar
  10. 10.
    R. Degwitz, K.F. Binsack, H. Herkert, Zur problem der persistierenden extrapyramidelen Hyperkinesen nach langfritiger anwendang von Neuroleptica. Nervenarzt 38: 170–174 (1967).Google Scholar
  11. 11.
    F.J. Ayd, A survey of drug-induced extrapyramidal reactions. JAMA 175: 1054–1060 (1961).PubMedCrossRefGoogle Scholar
  12. 12.
    F.J. Ayd, Neuroleptics and extrapyramidal reactions in psychiatric patients. Rev. Can. Biol. 20: 451–459 (1961).PubMedGoogle Scholar
  13. 13.
    J.B. Martin, S. Lai, G. Tolis and H.G. Friesen, Inhibition by apomorphine of prolactin secretion in patients with elevated serum prolactin. J. Clin. Endocrin. and Metab. 39: 180–182 (1974).CrossRefGoogle Scholar
  14. 14.
    G. Selvy, Parkinson’s disease, in, “Handbook of Clinical Neurology,” Diseases of the Basal Ganglia, B. Vinken, G.W. Bruyn eds., Amsterdam, Elsevier (1968).Google Scholar
  15. 15.
    C. Goetz, W.J. Weiner and H.L. Klawans, Treatment of the choreas, in, “Disorders of Movement,” A. Barbeau ed., Philadelphia, Lippincott (1981).Google Scholar
  16. 16.
    G. Gardos, J. O. Cole and D. Tarsy, D.: Withdrawal syndromes associated with antipsychotic drugs. Am. J. Psych. 135: 1321–1324 (1978).Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Christopher G. Goetz
    • 1
  1. 1.Rush-Presbyterian St. Lukes Medical CenterChicagoUSA

Personalised recommendations